"Passionate about improving cattle health & welfare through innovation, excellence & valued & trusted customer support."

About Us

Boehringer Ingelheim is the world’s largest privately owned pharmaceutical company and is owned by the Boehringer family with Global Headquarters in Ingelheim, Germany. Boehringer Ingelheim invests a major part of its income every year into the research and development to secure a long-term supply of innovative solutions aimed at improving the health of humans and animals (pets and livestock) throughout the world.

Within the organisation exists a thriving and successful Animal Health business, Boehringer Ingelheim Vetmedica which is responsible for the company’s animal health portfolio catering for cats, dogs, horses, cattle and pigs. Boehringer Ingelheim Vetmedica is the 5th largest animal health company in the UK.

The cattle team at Boehringer is made up of dedicated specialists, vets with years of on-farm experience as well as others who have worked intimately with cattle in other roles for most of their working lives. They all have a passion to improve the health and welfare of cattle through innovation, excellence and valued and trusted customer support.

Boehringer Ingelheim Vetmedica supports many local and international initiatives aimed at achieving its goal of improving the health and welfare of cattle. The annual international Well-being symposium (www.farmanimalwellbeing.eu) is just one example of how the company supports this aim by bringing together experts in the field of health and welfare to share the latest developments in this important area and thereby move the debate along to the benefit of cattle.

For more information on Boehringer Ingelheim or its animal health business please visit www.boehringer-ingelheim.co.uk

Our corporate vision - "Value through Innovation"

The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us to build on our strengths and make the most of our distinctive character. In a competitive and fast-changing world, the value of products, services and companies is constantly changing. Real customer value today can only be created by constantly developing new solutions and doing what we already do, but better.

An educational service from Boehringer Ingelheim Limited, Vetmedica Division, the makers of Metacam®, Bovikalc®, Ubrolexin®, Ubro Yellow®, Ubro Red® and Mamyzin®.

Advice on the use of Metacam, Bovikalc or other therapies should be sought from your veterinary surgeon. Metacam contains meloxicam, UK: POM-V IE: POM. Bovikalc contains calcium chloride and calcium sulphate and is not a veterinary medicine which is subject to authorisation by the Irish Medicines Board. Further information available from Boehringer Ingelheim Limited, Vetmedica Division, Bracknell, Berkshire, RG12 8YS, UK. Email: vetmedica.uk@boehringer-ingelheim.com | Web: www.boehringer-ingelheim.co.uk

See our Terms of Use

Date of preparation: Jul 2013. AHD 7729. Use Medicines Responsibly (www.noah.co.uk/responsible)